當前位置：首頁 SCI期刊 SCIE期刊醫學中科院4區 JCRQ2 期刊介紹(非官網)

Clinics And Research In Hepatology And GastroenterologySCIE

國際簡稱：CLIN RES HEPATOL GAS 參考譯名：肝病學和胃腸病學的診所和研究

中科院分區
4區
CiteScore分區
Q2
JCR分區
Q2

基本信息：: ISSN：2210-7401; E-ISSN：2210-741X; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：FRANCE; 出版商：Elsevier Masson; 出版語言：English; 出版周期：6 issues/year; 出版年份：2011; 研究方向：GASTROENTEROLOGY & HEPATOLOGY

評價信息：: 影響因子：2.6; H-index：51; CiteScore指數：4.3; SJR指數：0.676; SNIP指數：0.616

發文數據：: Gold OA文章占比：27.16%; 研究類文章占比：73.87%; 年發文量：111; 自引率：0.0370...; 開源占比：0.105; 出版撤稿占比：0; 出版國人文章占比：0.23; OA被引用占比：0.0018...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Clinics And Research In Hepatology And Gastroenterology期刊介紹

Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology. The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues. Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews. The journal encourages research and discussion between all those involved in the specialty on an international level. All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).

Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option). Your article will be available to all researchers around the globe whose institution has a subscription to the journal.

期刊簡介Clinics And Research In Hepatology And Gastroenterology期刊介紹

《Clinics And Research In Hepatology And Gastroenterology》自2011出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：偏慢,4-8周
醫學
GASTROENTEROLOGY & HEPATOLOGY
SCIE
中科院4區
非預警

Cite Score數據（2024年最新版）Clinics And Research In Hepatology And Gastroenterology Cite Score數據

CiteScore：4.3
SJR：0.676
SNIP：0.616

學科類別	分區	排名	百分位
大類：Medicine 小類：Gastroenterology	Q2	77 / 167	54%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Clinics And Research In Hepatology And Gastroenterology 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	4區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Clinics And Research In Hepatology And Gastroenterology JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	67 / 143	53.5%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	70 / 143	51.4%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
France134
CHINA MAINLAND124
Italy36
GERMANY (FED REP GER)35
USA32
Spain22
Portugal11
Belgium10
Brazil9
Switzerland9

本刊中國學者近年發表論文

1、Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial
Author: Liu, Dan-Ni; Wang, Qiu-Yan; Li, Pei -Yuan; Wu, Dong-Han; Pan, Jing; Chen, Zheng-Yi; Li, Yan-Qiang; Han, Xiang-Yang; Lan, Cheng; Tang, Jing; Tan, Yan; Mo, Cui-Yi; Yang, Wei-Zhong; Han, Jun-Ling; Huang, Xiao-Xi

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 5, pp. -. DOI: 10.1016/j.clinre.2023.102125
2、Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis
Author: Du, Fei; Zhang, Lingkai; Zhang, Yongxuan; Fan, Haining; Ren, Li

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102069
3、Metabolic-associated fatty liver disease and the risk of cardiovascular disease
Author: Zhang, Pengwei; Dong, Xianhui; Zhang, Wei; Wang, Shiyin; Chen, Chen; Tang, Jiake; You, Yao; Hu, Siqi; Zhang, Shenghui; Wang, Chunyi; Wen, Wen; Zhou, Mengyun; Tan, Tao; Qi, Guanming; Li, Li; Wang, Mingwei

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102063
4、The addition of camrelizumab is effective and safe among unresectable hepatocellular carcinoma patients who progress after drug-eluting bead transarterial chemoembolization plus apatinib therapy
Author: Wang, Manzhou; Sun, Limin; Han, Xinwei; Ren, Jianzhuang; Li, Hao; Wang, Wenhui; Xu, Wenze; Liang, Chao; Duan, Xuhua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102060
5、Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019
Author: Tian, Hongzhan; Zhang, Kexin; Hui, Zongguang; Ren, Fangbing; Ma, Yanhui; Han, Fang; Sun, Xiaodong; Kan, Chengxia; Hou, Ningning

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102068
6、LncRNA ZFAS1 ameliorates injury led by non- alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation
Author: Liu, Lu; Sun, Sen; Li, Xiaohua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102067
7、Transarterial chemoembolization failure in patients with hepatocellular carcinoma: Incidence, manifestation and risk factors
Author: Zhang, Lijie; Zhang, Xin; Li, Qing; Makamure, Joyman; Liu, Ziyi; Zhao, Dan; Li, Xin; Shi, Heshui; Zheng, Chuansheng; Liu, Fengyong; Liang, Bin

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102071
8、T lymphocyte-mediated pyroptosis: A new regulatory mechanism in non-viral liver disease
Author: Xiong, Wanyuan; Qian, Zibing; Mao, Xiaorong; Li, Junfeng

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102070